Su, Su
Zhu, Xuelu
Wu, Shiqi
Ma, Wenyao
Yan, Suying
Zhang, Lan
Funding for this research was provided by:
Capital Fund for Health Improvement and Research (2022-2Z-20113)
Beijing Municipal Health Commission Funded Project (11000022T000000444688)
Beijing Municipal Science and Technology Commission, Adminitrative Commission of Zhongguancun Science Park (D181100000218002)
Special research project on monitoring and evaluation of the use of key clinical drugs by the committee for drug evaluation of Chinese research hospital association (Y2024FH-YWPJ02)
Drug Safety Research Project by the Drug related Disease Research Committee of Chinese Pharmacological Society (ADR2024MS14)
Capital Medical University Undergraduate Research and Innovation Program (XSKY2024439)
Article History
Received: 13 May 2024
Accepted: 18 September 2024
First Online: 3 October 2024
Change Date: 2 March 2025
Change Type: Update
Change Details: The original online version of this article was revised: The term “marginal change” in Results section, table 4 and supplementary file have been corrected as “estimated mean costs”. And the supplementary file 2 has been replaced with the correct file
Change Date: 8 March 2025
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1007/s11096-025-01884-5
Conflicts of interest
: The authors declare no conflicts of interest.